News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Sleep-Aligned Fasting May Support Overnight Heart Health
July 9, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Researchers found that aligning fasting with the body’s natural sleep cycle before bedtime may support cardiovascular and metabolic health.
Read Article
AMP® BGTC Announces FDA Clearance of Investigational New Drug Application for Gene Therapy Targeting Multiple Sulfatase Deficiency
July 6, 2026 - Grantee/Partner News
- Bespoke Gene Therapy Consortium (BGTC)
The FDA cleared the Investigational New Drug (IND) application for a gene therapy designed to treat children with multiple sulfatase deficiency (MSD), an ultra-rare disease.
Read ArticleTiny Antibodies May Provide New Tool to Fight COVID-19
August 30, 2022 - NCATS News
- COVID-19
An NIH-led team of scientists built a library of small antibodies, called synthetic nanobodies, to speed the search for therapeutics to combat new SARS-CoV-2 variants. They identified three nanobodies that seemed most effective in blocking infection.
Nationwide IRB Reliance Agreement Aimed at Speeding Research Reaches 1,000 Signatories
August 3, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
- Our Impact on Research Operations
The Streamlined, Multisite, Accelerated Resources for Trials (SMART) Institutional Review Board (IRB) agreement has reached 1,000 participating sites, making it one of the largest medical research study reliance agreements in the United States.
COVID-19 Hospitalization May Increase Heart Failure Risk
July 15, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
- National Clinical Cohort Collaborative (N3C)
- Our Impact on Big Data
A large, retrospective study using National COVID Cohort Collaborative (N3C) data revealed that people who had been hospitalized with COVID-19 were more likely to develop heart failure during their recovery than people who had been hospitalized without COVID-19.
Media Advisory: To Find Answers for People on Earth, NIH-Funded Tissue Chips Take Flight
July 13, 2022 - NCATS News
- Tissue Chip for Drug Screening
Two NIH-funded research teams will send tissue chips to the International Space Station National Laboratory (ISS-NL). The tissue chips will spend several weeks in orbit to collect information about why the aging process causes muscles to lose mass and strength and the immune system to work less effectively.
Study Finds Immune Dysfunction Is a Significant Risk Factor for COVID-19 Breakthrough Infection
June 3, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
The National COVID Cohort Collaborative Data Enclave helps researchers identify a link between COVID-19 breakthrough infections and people with abnormal or impaired immune systems.
Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19
June 2, 2022 - NCATS News
- COVID-19
- Clinical and Translational Science Awards (CTSA) Program
A large NCATS-coordinated, randomized, placebo-controlled clinical trial showed that treating adults hospitalized with COVID-19 with infliximab or abatacept — drugs widely used to treat certain autoimmune diseases — substantially improved clinical status and reduced deaths but did not significantly shorten time to recovery.